Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.

COVID-19 SARS-CoV-2 household serology transmission

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 11 12 2020
accepted: 23 03 2021
entrez: 26 7 2021
pubmed: 27 7 2021
medline: 27 7 2021
Statut: epublish

Résumé

Research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission within households and other close settings using serological testing is scarce. We invited coronavirus disease 2019 (COVID-19) cases diagnosed between February 27 and April 1, 2020, in Canton of Vaud, Switzerland, to participate, along with household members and other close contacts. Anti-SARS-CoV-2 immunoglobulin G antibodies were measured using a Luminex immunoassay. We estimated factors associated with serological status using generalized estimating equations. Overall, 219 cases, 302 household members, and 69 other close contacts participated between May 4 and June 27, 2020. More than half of household members (57.2%; 95% CI, 49.7%-64.3%) had developed a serologic response to SARS-CoV-2, while 19.0% (95% CI, 10.0%-33.2%) of other close contacts were seropositive. After adjusting for individual and household characteristics, infection risk was higher in household members aged ≥65 years than in younger adults (adjusted odds ratio [aOR], 3.63; 95% CI, 1.05-12.60) and in those not strictly adhering to simple hygiene rules like hand washing (aOR, 1.80; 95% CI, 1.02-3.17). The risk was lower when more than 5 people outside home were met during semiconfinement, compared with none (aOR, 0.35; 95% CI, 0.16-0.74). Individual risk of household members to be seropositive was lower in large households (22% less per each additional person). During semiconfinement, household members of a COVID-19 case were at very high risk of getting infected, 3 times more than close contacts outside home. This highlights the need to provide clear messages on protective measures applicable at home. For elderly couples, who were especially at risk, providing external support for daily basic activities is essential.

Sections du résumé

BACKGROUND BACKGROUND
Research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission within households and other close settings using serological testing is scarce.
METHODS METHODS
We invited coronavirus disease 2019 (COVID-19) cases diagnosed between February 27 and April 1, 2020, in Canton of Vaud, Switzerland, to participate, along with household members and other close contacts. Anti-SARS-CoV-2 immunoglobulin G antibodies were measured using a Luminex immunoassay. We estimated factors associated with serological status using generalized estimating equations.
RESULTS RESULTS
Overall, 219 cases, 302 household members, and 69 other close contacts participated between May 4 and June 27, 2020. More than half of household members (57.2%; 95% CI, 49.7%-64.3%) had developed a serologic response to SARS-CoV-2, while 19.0% (95% CI, 10.0%-33.2%) of other close contacts were seropositive. After adjusting for individual and household characteristics, infection risk was higher in household members aged ≥65 years than in younger adults (adjusted odds ratio [aOR], 3.63; 95% CI, 1.05-12.60) and in those not strictly adhering to simple hygiene rules like hand washing (aOR, 1.80; 95% CI, 1.02-3.17). The risk was lower when more than 5 people outside home were met during semiconfinement, compared with none (aOR, 0.35; 95% CI, 0.16-0.74). Individual risk of household members to be seropositive was lower in large households (22% less per each additional person).
CONCLUSIONS CONCLUSIONS
During semiconfinement, household members of a COVID-19 case were at very high risk of getting infected, 3 times more than close contacts outside home. This highlights the need to provide clear messages on protective measures applicable at home. For elderly couples, who were especially at risk, providing external support for daily basic activities is essential.

Identifiants

pubmed: 34307723
doi: 10.1093/ofid/ofab149
pii: ofab149
pmc: PMC8083624
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofab149

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
Int J Public Health. 2020 Dec;65(9):1529-1548
pubmed: 33098441
Clin Infect Dis. 2020 Jun 16;:
pubmed: 32544949
Clin Microbiol Infect. 2020 Sep;26(9):1178-1182
pubmed: 32593741
Glob Transit. 2020;2:76-82
pubmed: 32835202
J Virol. 2021 Jan 13;95(3):
pubmed: 33144321
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):606-610
pubmed: 32407303
Nat Med. 2020 Aug;26(8):1196-1199
pubmed: 32641783
Lancet Infect Dis. 2020 Oct;20(10):1141-1150
pubmed: 32562601
PLoS One. 2020 Aug 14;15(8):e0237833
pubmed: 32797108
BMJ Evid Based Med. 2020 Aug 11;:
pubmed: 32788164
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32597750
Lancet Infect Dis. 2021 Feb;21(2):168
pubmed: 32553187
Clin Infect Dis. 2020 Nov 19;71(16):2099-2108
pubmed: 32392331
Public Health. 2020 Aug;185:57-59
pubmed: 32563739
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Lancet Infect Dis. 2020 Oct;20(10):1103-1104
pubmed: 32562602
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Emerg Infect Dis. 2020 Aug;26(8):1671-1678
pubmed: 32470316
Clin Infect Dis. 2020 Nov 5;71(8):1953-1959
pubmed: 32382743
Emerg Infect Dis. 2020 Oct;26(10):2465-2468
pubmed: 32673193
JAMA Netw Open. 2020 Dec 1;3(12):e2031756
pubmed: 33315116
Lancet Infect Dis. 2021 Mar;21(3):333-343
pubmed: 33152271
Lancet Infect Dis. 2020 Aug;20(8):920-928
pubmed: 32422201
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347
PLoS Med. 2020 Oct 1;17(10):e1003358
pubmed: 33001967

Auteurs

Julien Dupraz (J)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Audrey Butty (A)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Olivier Duperrex (O)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Sandrine Estoppey (S)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Vincent Faivre (V)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Julien Thabard (J)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Claire Zuppinger (C)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Gilbert Greub (G)

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Service of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Giuseppe Pantaleo (G)

Service of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Swiss Vaccine Research Institute, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Jérôme Pasquier (J)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Valentin Rousson (V)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Malik Egger (M)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Amélie Steiner-Dubuis (A)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Sophie Vassaux (S)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Eric Masserey (E)

Cantonal Medical Office, Department of Health and Social Action, Canton of Vaud, Switzerland.

Murielle Bochud (M)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Semira Gonseth Nusslé (S)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Valérie D'Acremont (V)

Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Swiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.

Classifications MeSH